US2467434A
(en)
|
1947-05-10 |
1949-04-19 |
Air Associates Inc |
Servomotor and pressure responsive valve therefor
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4361549A
(en)
|
1979-04-26 |
1982-11-30 |
Ortho Pharmaceutical Corporation |
Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
|
US4452773A
(en)
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
DE3583940D1
(de)
|
1984-10-02 |
1991-10-02 |
Harry M Meade |
Herstellung von streptavidinaehnlichen polypeptiden.
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
US4795698A
(en)
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
IN165717B
(fr)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
US4851341A
(en)
|
1986-12-19 |
1989-07-25 |
Immunex Corporation |
Immunoaffinity purification system
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
US6303121B1
(en)
|
1992-07-30 |
2001-10-16 |
Advanced Research And Technology |
Method of using human receptor protein 4-1BB
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
US6534055B1
(en)
*
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
ES2067018T3
(es)
|
1988-12-28 |
1995-03-16 |
Stefan Miltenyi |
Procedimiento y materiales para la separacion en alto gradiente magnetico de materiales biologicos.
|
US5200084A
(en)
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
CA2096222C
(fr)
|
1990-11-13 |
1998-12-29 |
Stephen D. Lupton |
Genes de fusion selectables et bifonctionnelles
|
GB9215540D0
(en)
|
1992-07-22 |
1992-09-02 |
Celltech Ltd |
Protein expression system
|
DE4237113B4
(de)
|
1992-11-03 |
2006-10-12 |
"Iba Gmbh" |
Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
|
AU6953394A
(en)
|
1993-05-21 |
1994-12-20 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
DE69434342T2
(de)
|
1993-06-04 |
2006-03-16 |
The United States Of America Represented By The Secretary Of The Navy |
Verfahren zur selektiven Stimulierung der T-Zellproliferation.
|
DE4417598A1
(de)
|
1994-05-19 |
1995-12-14 |
Max Planck Gesellschaft |
Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen
|
US7074904B2
(en)
|
1994-07-29 |
2006-07-11 |
Altor Bioscience Corporation |
MHC complexes and uses thereof
|
AU696177B2
(en)
|
1994-07-29 |
1998-09-03 |
Sunol Molecular Corporation |
Mhc complexes and uses thereof
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
WO1996023879A1
(fr)
|
1995-01-30 |
1996-08-08 |
Terrapin Technologies, Inc. |
Corps agglutinants - multiplicite de proteines capables de lier diverses petites molecules
|
WO1996024606A1
(fr)
|
1995-02-09 |
1996-08-15 |
University Of Washington |
Streptavidine a affinite modifiee
|
WO1997011183A1
(fr)
|
1995-04-11 |
1997-03-27 |
Trustees Of Boston University |
Proteines mutantes de streptavidine
|
US5629205A
(en)
|
1995-05-19 |
1997-05-13 |
Allelix Biopharmaceuticals Inc. |
Promoters for gene expression
|
AR005035A1
(es)
|
1995-12-11 |
1999-04-07 |
Merck Patent Ges Mit Beschränkter Haftung |
Procedimiento para preparar proteinas recombinantes en e. coli, mediante fermentacion con gran concentracion de celulas.
|
US5869270A
(en)
|
1996-01-31 |
1999-02-09 |
Sunol Molecular Corporation |
Single chain MHC complexes and uses thereof
|
US5773224A
(en)
|
1996-02-12 |
1998-06-30 |
Grandics; Peter |
Immunoselection system for cell elution
|
DE19608753C1
(de)
|
1996-03-06 |
1997-06-26 |
Medigene Gmbh |
Transduktionssystem und seine Verwendung
|
US6451995B1
(en)
|
1996-03-20 |
2002-09-17 |
Sloan-Kettering Institute For Cancer Research |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
|
DE19637718A1
(de)
|
1996-04-01 |
1997-10-02 |
Boehringer Mannheim Gmbh |
Rekombinante inaktive Core-Streptavidin Mutanten
|
US6022688A
(en)
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
DE69730038T2
(de)
|
1996-08-16 |
2004-11-25 |
The President And Fellows Of Harvard College, Cambridge |
Lösliche monovalente und multivalente mhc klasse ii fusionsproteine und deren verwendungen
|
DE19641876B4
(de)
|
1996-10-10 |
2011-09-29 |
Iba Gmbh |
Streptavidinmuteine
|
US6368813B1
(en)
|
1997-03-14 |
2002-04-09 |
The Trustees Of Boston University |
Multiflavor streptavidin
|
US6391571B1
(en)
|
1997-04-01 |
2002-05-21 |
Roche Diagnostics Gmbh |
Recombinant inactive avidin mutants
|
WO1999014236A1
(fr)
|
1997-09-16 |
1999-03-25 |
Oregon Health Sciences University |
Molecules de cmh recombinees utiles pour la manipulation de cellules t specifiques a un antigene
|
US6232445B1
(en)
|
1997-10-29 |
2001-05-15 |
Sunol Molecular Corporation |
Soluble MHC complexes and methods of use thereof
|
US5985658A
(en)
|
1997-11-14 |
1999-11-16 |
Health Research Incorporated |
Calmodulin-based cell separation technique
|
BR9908082A
(pt)
|
1998-02-19 |
2000-10-31 |
Harvard College |
Proteìna de fusão do complexo de histocompatibilidade principal classe ii, conjugado dos domìnios de ligação do complexo de histocompatibilidade principal multimérico, processos para detectar células t tendo uma especificidade do complexo definido de mhc / peptìdeo, para conferir a um indivìduo imunidade adotiva a um complexo definido de mhc / peptìdeo, para estimular ou ativar as células t reativas a um complexo definido de mhc / peptìdeo, para seletivamente matar células t reativas a um complexo definido de mhc / peptìdeo, para tolerizar um indivìduo humano a um complexo definido de mhc / peptìdeo, e, ácido nucleico isolado
|
ES2249907T3
(es)
|
1998-05-23 |
2006-04-01 |
Leiden University Medical Center |
Anticuerpos de union cd40 y peptidos ctl para el tratamiento de tumores.
|
WO2000014257A1
(fr)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Recepteurs de fusion specifiques a l'antigene prostatique specifique membranaire et ses utilisations
|
US6410319B1
(en)
|
1998-10-20 |
2002-06-25 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
WO2000043551A1
(fr)
|
1999-01-26 |
2000-07-27 |
Cornell Research Foundation, Inc. |
Determination de charge virale dans les lymphocytes t negatifs doubles
|
AU759719B2
(en)
|
1999-02-04 |
2003-04-17 |
Pluristem Ltd. |
Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
|
EP1048732A1
(fr)
|
1999-04-26 |
2000-11-02 |
F. Hoffmann-La Roche Ag |
Procédé de préparation des protéine secretées sous une forme pliée naturelle
|
WO2000069549A1
(fr)
|
1999-05-14 |
2000-11-23 |
Pall Corporation |
Membrane chargee
|
US6849185B1
(en)
|
1999-05-14 |
2005-02-01 |
Pall Corp |
Charged membrane
|
EP1669129A1
(fr)
|
1999-05-14 |
2006-06-14 |
Pall Corporation |
Membrane électriquement chargée
|
CA2376665C
(fr)
|
1999-06-07 |
2014-02-25 |
Wolfgang Hillen |
Proteines de regulation transcriptionnelle basees sur un represseur tet
|
DE19932688B4
(de)
|
1999-07-13 |
2009-10-08 |
Scil Proteins Gmbh |
Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
|
AU3662101A
(en)
|
2000-02-01 |
2001-08-14 |
Tanox Inc |
Cd40-binding apc-activating molecules
|
US20030235908A1
(en)
|
2000-02-24 |
2003-12-25 |
Xcyte Therapies, Inc. |
Activation and expansion of cells
|
US20020131960A1
(en)
|
2000-06-02 |
2002-09-19 |
Michel Sadelain |
Artificial antigen presenting cells and methods of use thereof
|
US6638728B1
(en)
|
2000-06-16 |
2003-10-28 |
Pierce Biotechnology, Inc. |
Coated surfaces with high capacity for capturing target molecules
|
ATE426674T1
(de)
|
2000-11-03 |
2009-04-15 |
Genentech Inc |
Stoffwechselanderungen in garungen zur produktion rekombinanter proteine
|
AU2001297703B2
(en)
|
2000-11-07 |
2006-10-19 |
City Of Hope |
CD19-specific redirected immune cells
|
US6979556B2
(en)
|
2000-12-14 |
2005-12-27 |
Genentech, Inc. |
Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
|
EP1227321A1
(fr)
|
2000-12-28 |
2002-07-31 |
Institut für Bioanalytik GmbH |
Purification fonctionelle de lymphocytes T antigène-spécifiques par marquage réversible aux multimères MHC
|
WO2002055992A2
(fr)
|
2001-01-12 |
2002-07-18 |
Becton Dickinson Co |
Proteines de fusion mhc auto-multimerisantes et intrinsequement fluorescentes et complexes formes de ces proteines
|
GB0102568D0
(en)
|
2001-02-01 |
2001-03-21 |
Magnetic Biosolutions Sweden A |
Method
|
DE10113776B4
(de)
|
2001-03-21 |
2012-08-09 |
"Iba Gmbh" |
Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
MXPA04001566A
(es)
|
2001-08-27 |
2004-05-17 |
Genentech Inc |
Un sistema para expresion y ensamblado de anticuerpos.
|
EP1908769A1
(fr)
|
2001-08-27 |
2008-04-09 |
Genentech, Inc. |
Système d'expression d'anticorps et ensemble
|
WO2003029462A1
(fr)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteines de la lipocaline neutrophile humaine associee a la gelatinase et de proteines apparentees
|
US7094579B2
(en)
|
2002-02-13 |
2006-08-22 |
Xoma Technology Ltd. |
Eukaryotic signal sequences for prokaryotic expression
|
US8076452B2
(en)
|
2002-03-01 |
2011-12-13 |
Erdmann Volker A |
Streptavidin-binding peptide
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
US7754155B2
(en)
|
2002-03-15 |
2010-07-13 |
Ross Amelia A |
Devices and methods for isolating target cells
|
WO2003090781A1
(fr)
|
2002-04-23 |
2003-11-06 |
Meir Strahilevitz |
Procedes et dispositifs permettant de cibler un site chez un mammifere et d'oter des especes chimiques d'un mammifere
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
WO2007001459A2
(fr)
|
2004-11-15 |
2007-01-04 |
Washington University |
Compositions et procedes pour moduler l'activite lymphocytaire
|
DE10393326D2
(de)
|
2002-06-24 |
2005-06-02 |
Profos Ag |
Verfahren zum Nachweis und zur Entfernung von Endotoxin
|
FR2841905B1
(fr)
|
2002-07-05 |
2004-09-03 |
Centre Nat Rech Scient |
Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications
|
JP4726483B2
(ja)
|
2002-07-17 |
2011-07-20 |
サイトス バイオテクノロジー アーゲー |
分子抗原アレイ
|
GB2392158B
(en)
|
2002-08-21 |
2005-02-16 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof
|
US8895298B2
(en)
|
2002-09-27 |
2014-11-25 |
The General Hospital Corporation |
Microfluidic device for cell separation and uses thereof
|
JP4773947B2
(ja)
|
2003-01-09 |
2011-09-14 |
マクロジェニクス,インコーポレーテッド |
細菌細胞及び哺乳動物細胞における抗体発現のための二重発現ベクター系
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
AU2004234627A1
(en)
|
2003-05-02 |
2004-11-11 |
Insception Bioscience, Inc. |
Apparatus and methods for amplification of blood stem cell numbers
|
ATE481476T1
(de)
|
2003-05-08 |
2010-10-15 |
Life Technologies Corp |
Erzeugung und isolierung antigenspezifischer t- zellen
|
US7435592B2
(en)
|
2003-05-13 |
2008-10-14 |
Immunovative Therapies, Ltd. |
Compositions for allogeneic cell therapy
|
US7943393B2
(en)
|
2003-07-14 |
2011-05-17 |
Phynexus, Inc. |
Method and device for extracting an analyte
|
SI1656455T1
(sl)
|
2003-08-13 |
2012-12-31 |
Sandoz Ag |
Postopek za čiščenje rekombinantnih polipeptidov
|
GB0319601D0
(en)
|
2003-08-20 |
2003-09-24 |
Sandoz Ag |
Production process
|
GB0321100D0
(en)
|
2003-09-09 |
2003-10-08 |
Celltech R&D Ltd |
Biological products
|
GB2408507B
(en)
|
2003-10-06 |
2005-12-14 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof for specific targeting
|
KR100570422B1
(ko)
|
2003-10-16 |
2006-04-11 |
한미약품 주식회사 |
대장균 분비서열을 이용하여 항체 단편을 분비·생산하는 발현벡터 및 이를 이용하여 항체 단편을 대량 생산하는 방법
|
JP2007512528A
(ja)
|
2003-11-20 |
2007-05-17 |
バイオセンサー、アプリケーションズ、スエーデン、アクチボラグ |
所定の抗原混合物に特異的な少なくとも2種類の異なる抗体の混合物およびその混合物の使用
|
CA2546157C
(fr)
|
2003-11-21 |
2014-07-22 |
Dow Global Technolgies Inc. |
Systemes d'expression ameliores a secretion du systeme sec
|
SE0400181D0
(sv)
|
2004-01-29 |
2004-01-29 |
Gyros Ab |
Segmented porous and preloaded microscale devices
|
US7592431B2
(en)
|
2004-02-26 |
2009-09-22 |
Immunovative Therapies, Ltd. |
Biodegradable T-cell Activation device
|
ZA200606913B
(en)
|
2004-03-11 |
2008-03-26 |
Genentech Inc |
Process for producing polypeptides
|
DE602005013957D1
(de)
|
2004-06-03 |
2009-05-28 |
Meso Scale Technologies Llc |
Verfahren zur durchführung von vollbluttests
|
EP1800136B1
(fr)
|
2004-10-15 |
2011-12-07 |
Danisco US Inc. |
Criblage differentiel competitif
|
BRPI0419117A
(pt)
|
2004-11-12 |
2007-12-11 |
Genentech Inc |
ácido nucléico isolado, vetor, célula hospedeira, processo para produção, polipeptìdeo isolado, molécula quimérica, anticorpo, anticorpo isolado, composição de interesse, artigo de fabricação, método de alìvio de uma disfunção imune relacionada, método para determinar a presença de um polipeptìdeo em uma amostra suspeita de conter dito polipeptìdeo, método de diagnóstico de uma doença imune relacionada em um mamìfero, método de alìvio de linfoma em um mamìfero em necessidade deste, método de alìvio de doença inflamatória de intestino em um mamìfero em necessidade deste e método de alìvio de rejeição de células transplantadas em um mamìfero
|
WO2006058226A2
(fr)
|
2004-11-24 |
2006-06-01 |
The Trustees Of Boston University |
Streptavidines dimeres modifiees et leurs utilisations
|
EP1827604B1
(fr)
|
2004-12-10 |
2019-11-20 |
Peter MacCallum Cancer Institute |
Procedes et compositions pour l' immunotherapie adoptive
|
US20060252087A1
(en)
|
2005-01-18 |
2006-11-09 |
Biocept, Inc. |
Recovery of rare cells using a microchannel apparatus with patterned posts
|
US20110027220A1
(en)
|
2005-09-28 |
2011-02-03 |
Cytos Biotechnology Ag |
Interleukin-1 Conjugates and Uses Thereof
|
US7704708B2
(en)
|
2006-02-13 |
2010-04-27 |
Uti Limited Partnership |
Monomeric streptavidin muteins
|
US7855057B2
(en)
|
2006-03-23 |
2010-12-21 |
Millipore Corporation |
Protein splice variant/isoform discrimination and quantitative measurements thereof
|
US20090208471A1
(en)
|
2006-04-07 |
2009-08-20 |
Yun Theodore J |
Isolation and Use of Human Regulatory T Cells
|
GB2442048B
(en)
|
2006-07-25 |
2009-09-30 |
Proimmune Ltd |
Biotinylated MHC complexes and their uses
|
US20080085532A1
(en)
|
2006-09-18 |
2008-04-10 |
Jorn Gorlach |
Method for determining the immune status of a subject
|
EP1905839B2
(fr)
|
2006-09-22 |
2019-07-10 |
Wacker Chemie AG |
Procédé de production de protéines fermentative
|
DE502006009060D1
(de)
|
2006-09-22 |
2011-04-21 |
Wacker Chemie Ag |
Verfahren zur fermentativen Herstellung von Antikörpern
|
DK1903105T3
(da)
|
2006-09-22 |
2010-06-28 |
Wacker Chemie Ag |
Fremgangsmåde til fermentativ fremstilling af proteiner
|
DE102006044841A1
(de)
|
2006-09-22 |
2008-04-03 |
Wacker Chemie Ag |
Signalpeptid zur Produktion von rekombinanten Proteinen
|
KR101454287B1
(ko)
|
2006-10-17 |
2014-11-04 |
온코세라피 사이언스 가부시키가이샤 |
Mphosph1 또는 depdc1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
|
GB0620894D0
(en)
|
2006-10-20 |
2006-11-29 |
Univ Southampton |
Human immune therapies using a CD27 agonist alone or in combination with other immune modulators
|
CN105699662A
(zh)
|
2006-11-02 |
2016-06-22 |
协和梅迪克斯株式会社 |
免疫测定待测组分的方法
|
CN101622340A
(zh)
|
2006-11-15 |
2010-01-06 |
茵维特罗根戴纳股份公司 |
生物素化合物与支持物可逆结合的方法
|
US20080131415A1
(en)
|
2006-11-30 |
2008-06-05 |
Riddell Stanley R |
Adoptive transfer of cd8 + t cell clones derived from central memory cells
|
CN101226118B
(zh)
|
2007-01-19 |
2010-06-16 |
中国医学科学院肿瘤研究所 |
一种兼容免疫荧光分析的细胞化学染色方法及其用途
|
EP2468869B1
(fr)
|
2007-01-31 |
2015-03-18 |
Pfenex Inc. |
Séquences leader bactériennes pour augmenter l'expression
|
KR20080076622A
(ko)
|
2007-02-16 |
2008-08-20 |
포항공과대학교 산학협력단 |
올리고머화된 단백질 전달체와 이를 이용한 세포내바이러스 벡터 전달 방법
|
EP2137308B1
(fr)
|
2007-03-26 |
2016-08-03 |
Agenus Inc. |
Affichage de surface d'une cellule, criblage et production de protéines d'intérêt
|
WO2008116468A2
(fr)
|
2007-03-26 |
2008-10-02 |
Dako Denmark A/S |
Complexes peptidiques du cmh et leurs utilisations dans des maladies infectieuses
|
EP3357338A1
(fr)
|
2007-03-30 |
2018-08-08 |
Memorial Sloan-Kettering Cancer Center |
Expression constitutive de ligands costimulants sur des lymphocytes t transférés de manière adoptive
|
JP5575636B2
(ja)
|
2007-05-07 |
2014-08-20 |
メディミューン,エルエルシー |
抗icos抗体ならびに、腫瘍、移植および自己免疫疾患の治療におけるその使用
|
EP2167537A2
(fr)
|
2007-07-03 |
2010-03-31 |
Dako Denmark A/S |
Procedes compiles pour analyser et trier des echantillons
|
WO2009024591A1
(fr)
|
2007-08-20 |
2009-02-26 |
Bio-Medisinsk Innovasjon As |
Expression à la surface des phages par l'intermédiaire de pvii
|
ES2319061B1
(es)
|
2007-09-11 |
2010-02-10 |
Biomedal, S.L. |
Metodo de conservacion de peptidos o proteinas.
|
EP2197908A2
(fr)
|
2007-09-27 |
2010-06-23 |
Dako Denmark A/S |
Multimères cmh dans le diagnostic, le vaccin et le traitement de la tuberculose
|
ES2640216T3
(es)
|
2007-12-07 |
2017-11-02 |
Miltenyi Biotec Gmbh |
Sistemas y métodos para procesamiento de células
|
US8479118B2
(en)
|
2007-12-10 |
2013-07-02 |
Microsoft Corporation |
Switching search providers within a browser search box
|
SG10201704689XA
(en)
|
2008-01-18 |
2017-07-28 |
Harvard College |
Methods of detecting signatures of disease or conditions in bodily fluids
|
JP2011510653A
(ja)
|
2008-01-29 |
2011-04-07 |
フレッド ハッチンソン キャンサー リサーチ センター |
CD161hiおよび/またはIL18Rahiであり、迅速な薬剤流出能力を有するCD8+T細胞の同定
|
US9212208B2
(en)
|
2008-01-30 |
2015-12-15 |
Pieris Ag |
Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same
|
EP2254592B1
(fr)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Multimères de mhc dans le diagnostic et le traitement de la borréliose
|
US20120164718A1
(en)
|
2008-05-06 |
2012-06-28 |
Innovative Micro Technology |
Removable/disposable apparatus for MEMS particle sorting device
|
JP5173594B2
(ja)
|
2008-05-27 |
2013-04-03 |
キヤノン株式会社 |
管理装置、画像形成装置及びそれらの処理方法
|
WO2010037395A2
(fr)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Multimères de mhc dans des vaccins et la surveillance immunitaire contre le cancer
|
CN101446576B
(zh)
|
2008-12-29 |
2011-06-22 |
江苏省苏微微生物研究有限公司 |
一种微囊藻毒素-lr单抗免疫亲和柱的制备和使用方法
|
WO2010080032A2
(fr)
|
2009-01-09 |
2010-07-15 |
Stichting Het Nederlands Kanker Instituut |
Transduction virale assistée par des billes
|
DE102009018647A1
(de)
|
2009-04-23 |
2010-10-28 |
Osram Opto Semiconductors Gmbh |
Strahlungsemittierende Vorrichtung
|
US20110070581A1
(en)
|
2009-04-27 |
2011-03-24 |
Amit Gupta |
Separation of Leukocytes
|
US20120214187A1
(en)
|
2009-11-02 |
2012-08-23 |
Ffina Biolutions, Llc |
Method for Enhancing the Sensitivity of Antibody Based Assays
|
KR101968766B1
(ko)
|
2009-11-05 |
2019-04-12 |
제넨테크, 인크. |
이종 폴리펩티드의 분비를 위한 방법 및 조성물
|
CA2781099A1
(fr)
|
2009-11-17 |
2011-05-26 |
Janssen Biotech, Inc. |
Secretion amelioree de proteines membranaires bacteriennes
|
US20120321665A1
(en)
|
2009-12-14 |
2012-12-20 |
Benaroya Research Institute At Virginia Mason |
Compositions and methods for treating airway inflammatory diseases
|
US9891148B2
(en)
|
2010-02-09 |
2018-02-13 |
Douglas T. Gjerde |
Method and apparatus for pipette tip columns
|
US9637719B2
(en)
|
2013-12-06 |
2017-05-02 |
Douglas T. Gjerde |
Devices and methods for purification of biological cells
|
US9370732B2
(en)
|
2013-02-15 |
2016-06-21 |
Douglas T. Gjerde |
Methods for purifying biological cells
|
US9242244B2
(en)
|
2010-02-09 |
2016-01-26 |
Douglas T. Gjerde |
Method and apparatus for pipette tip columns
|
GB201002730D0
(en)
|
2010-02-18 |
2010-04-07 |
Uni I Oslo |
Product
|
EP2363501A1
(fr)
|
2010-03-02 |
2011-09-07 |
Universitätsklinikum Hamburg-Eppendorf |
Nanocomposites dotés d'une homogénéité améliorée
|
JP5665021B2
(ja)
|
2010-03-08 |
2015-02-04 |
国立大学法人東京農工大学 |
融合mhc分子連結磁気微粒子、抗原ペプチドのスクリーニング方法、組換えベクター、及び磁性細菌の形質転換体
|
WO2011161086A2
(fr)
|
2010-06-23 |
2011-12-29 |
Stobbe Tech. A/S |
Dispositif et procédé pour la culture industrielle de cellules
|
GB201012603D0
(en)
|
2010-07-27 |
2010-09-08 |
Ucb Pharma Sa |
Protein purification
|
US9410157B2
(en)
|
2010-07-30 |
2016-08-09 |
Wisconsin Alumni Research Foundation |
Systems and methods for the secretion of recombinant proteins in gram negative bacteria
|
JP6192537B2
(ja)
|
2010-08-06 |
2017-09-06 |
ルードヴィヒ−マクシミリアン−ウニヴェルズィテート ミュンヘン |
T細胞の標的抗原の同定
|
WO2012044999A2
(fr)
|
2010-10-01 |
2012-04-05 |
Ludwig Institute For Cancer Research Ltd. |
Multimères de protéines réversibles, et leurs procédés de production et d'utilisation
|
WO2012058627A2
(fr)
|
2010-10-29 |
2012-05-03 |
Miqin Zhang |
Système de nanoparticules préciblées et procédé de marquage de particules biologiques
|
KR20230133410A
(ko)
|
2010-12-09 |
2023-09-19 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
암을 치료하기 위한 키메릭 항원 수용체 변형 t 세포의 용도
|
BR112013024395B1
(pt)
|
2011-03-23 |
2021-10-26 |
Fred Hutchinson Cancer Research Center |
Composições adotivas de imunoterapia celular e método para fabricação da dita composição
|
JP5840857B2
(ja)
|
2011-04-08 |
2016-01-06 |
国立大学法人 東京大学 |
細胞傷害性t細胞誘導用組成物
|
US8398282B2
(en)
|
2011-05-12 |
2013-03-19 |
Delphi Technologies, Inc. |
Vehicle front lighting assembly and systems having a variable tint electrowetting element
|
CN107843730B
(zh)
|
2011-07-18 |
2021-08-20 |
Iba生命科学股份有限公司 |
使靶细胞可逆染色的方法
|
US9353161B2
(en)
|
2011-09-13 |
2016-05-31 |
Uti Limited Partnership |
Streptavidin mutein exhibiting reversible binding for biotin and streptavidin binding peptide tagged proteins
|
GB201116092D0
(en)
|
2011-09-16 |
2011-11-02 |
Bioceros B V |
Antibodies and uses thereof
|
MX359234B
(es)
|
2011-11-11 |
2018-09-20 |
Hutchinson Fred Cancer Res |
Inmunoterapia de celulas t objetivadas en ciclina a1 para cancer.
|
AU2013221672B2
(en)
|
2012-02-13 |
2017-11-09 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
WO2013126726A1
(fr)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Lymphocytes t doubles transgéniques comportant un car et un tcr, et leurs procédés d'utilisation
|
US10228312B2
(en)
|
2012-02-23 |
2019-03-12 |
Juno Therapeutics Gmbh |
Chromatographic isolation of cells and other complex biological materials
|
BR112014027374B1
(pt)
|
2012-05-03 |
2022-05-31 |
Fred Hutchinson Cancer Research Center |
Método para gerar um receptor de células t (tcr) com afinidade aumentada
|
UA114108C2
(uk)
|
2012-07-10 |
2017-04-25 |
Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем |
Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
|
KR102332322B1
(ko)
|
2012-07-13 |
2021-12-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
형질도입된 t 세포의 투여 적합성을 평가하는 방법
|
KR102135239B1
(ko)
|
2012-08-20 |
2020-07-17 |
프레드 헛친슨 켄서 리서치 센터 |
세포 면역요법을 위한 방법 및 조성물
|
WO2014039044A1
(fr)
|
2012-09-06 |
2014-03-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Procédés de production de populations de cellules souches t mémoires
|
EP2711418B1
(fr)
|
2012-09-25 |
2017-08-23 |
Miltenyi Biotec GmbH |
Procédé de stimulation polyclonales de lymphocyte T par nanomatrices flexibles
|
CN104853766A
(zh)
|
2012-10-02 |
2015-08-19 |
纪念斯隆-凯特琳癌症中心 |
用于免疫疗法的组合物和方法
|
JP6475630B2
(ja)
|
2012-11-16 |
2019-02-27 |
イーベーアー ゲーエムベーハー |
ストレプトアビジン突然変異タンパク質およびそれらを使用する方法
|
WO2014097442A1
(fr)
|
2012-12-20 |
2014-06-26 |
三菱電機株式会社 |
Dispositif embarqué et programme
|
WO2014118220A1
(fr)
|
2013-01-31 |
2014-08-07 |
Glaxo Group Limited |
Procédé de production de protéine
|
US10220332B2
(en)
|
2013-02-15 |
2019-03-05 |
Douglas T. Gjerde |
Columns for isolation, detection and use of biological cells
|
US10107729B2
(en)
|
2013-02-15 |
2018-10-23 |
Douglas T. Gjerde |
Isolation, detection and use of biological cells
|
US9920294B2
(en)
|
2013-02-15 |
2018-03-20 |
Douglas T. Gjerde |
Devices and methods for purification, detection and use of biological cells
|
CN103305464B
(zh)
|
2013-06-05 |
2015-04-15 |
南昌大学 |
直接分离cd4+和cd8+淋巴细胞的方法
|
US9108442B2
(en)
|
2013-08-20 |
2015-08-18 |
Ricoh Company, Ltd. |
Image forming apparatus
|
DK3083671T3
(da)
|
2013-12-20 |
2020-12-07 |
Hutchinson Fred Cancer Res |
Mærkede kimære effektormolekyler og receptorer deraf
|
EP2886645A1
(fr)
|
2013-12-20 |
2015-06-24 |
Julius-Maximilians-Universität Würzburg |
Expansion de lymphocytes T humains in vitro par des anticorps monoclonaux anti-CD28 classiques liés à une bille
|
IL280738B
(en)
|
2014-04-16 |
2022-07-01 |
Juno Therapeutics Gmbh |
Methods, kits and device for increasing cell populations
|
EP3647412A1
(fr)
|
2014-04-23 |
2020-05-06 |
Juno Therapeutics, Inc. |
Procédés d'isolation, de culture et de modification génétique de populations de cellules immunitaires pour thérapie adoptive
|
CA2946222C
(fr)
|
2014-04-24 |
2020-12-22 |
Miltenyi Biotec Gmbh |
Procede de production automatisee de cellules t genetiquement modifiees
|
SI3134095T1
(sl)
|
2014-04-25 |
2020-08-31 |
Bluebird Bio, Inc. |
Izboljšani postopki za izdelavo adoptivnih celičnih terapij
|
US11150239B2
(en)
|
2014-04-30 |
2021-10-19 |
Iba Lifesciences Gmbh |
Method of isolating a target cell
|
WO2016166568A1
(fr)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil permettant d'augmenter une population de cellules
|
BR112018008111A2
(pt)
|
2015-10-22 |
2018-11-06 |
Juno Therapeutics Gmbh |
métodos, kits, agentes e aparelhos para transdução
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
EP4212547A1
(fr)
|
2015-12-03 |
2023-07-19 |
Juno Therapeutics, Inc. |
Récepteurs chimériques modifiés et compositions et procédés associés
|
US11517627B2
(en)
|
2017-01-20 |
2022-12-06 |
Juno Therapeutics Gmbh |
Cell surface conjugates and related cell compositions and methods
|
MA49288A
(fr)
|
2017-04-27 |
2020-03-04 |
Juno Therapeutics Gmbh |
Reactifs particulaires oligomères et leurs méthodes d'utilisation
|
US20190247846A1
(en)
|
2018-02-09 |
2019-08-15 |
Chris Suh |
Method and Apparatus for Pipette Tip Columns
|
MX2021001523A
(es)
|
2018-08-09 |
2021-05-27 |
Juno Therapeutics Inc |
Procesos para generar células modificadas y composiciones de las mismas.
|
KR20210098450A
(ko)
|
2018-10-31 |
2021-08-10 |
주노 테라퓨틱스 게엠베하 |
세포의 선택 및 자극을 위한 방법 및 이를 위한 장치
|
WO2022234009A2
(fr)
|
2021-05-06 |
2022-11-10 |
Juno Therapeutics Gmbh |
Méthodes de stimulation et de transduction de lymphocytes t
|